Board of Directors

AllerGen NCE Inc. is governed by an independent Board of Directors (BoD) committed to the vision and mission of the Network. Board Directors promote an atmosphere where research excellence and industry expertise unite to provide socio-economic benefits for Canadians. The BoD is responsible for the overall governance of the Network and acts in accordance with the By-Laws of AllerGen NCE Inc.

AllerGen’s BoD ensures that Network management pursues appropriate corporate directions and develops, maintains and implements investments, processes and strategic plans in accordance with Network policies and priorities.

Former Board Members

Current Board Members

Pieter Cullis (Chair) | academic/research, Vancouver BC




Pieter Cullis, PhD, FRSC (Chair)

Director, Life Sciences Institute; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, The University of British Columbia

Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems.

Sector: Academic/Research

Christine Hampson (Vice-Chair) | non-profit, Toronto ON


Christine Hampson, PhD


President and CEO, The Sandbox Project

Dr. Hampson is President & CEO of The Sandbox Project Charity, which aims to make measurable progress against international health indicators within the next five years, improving health outcomes with respect to injury prevention, obesity, mental health, and the environment in particular.

Sector: Non-Profit

Vanessa Foran | non-profit, Toronto ON


Vanessa Foran


President and CEO, Asthma Canada

Ms Foran is President and CEO of Asthma Canada, which provides information and services to help the 3 million Canadians with asthma.

Sector: Non-Profit

Daniel Nixon | private, Toronto ON


nixonDaniel Nixon, MBA


Director & Chief Financial Officer, Molecular You Corporation

Mr. Nixon is a seasoned executive with extensive private equity, investment banking and operations experience.

Sector: Private

Paul O'Byrne | clinical/academic, Hamilton ON


Paul O’Byrne, MB, FRCPI, FRCPC, FRCPE, FRCP(Glasg), FAPC, FCCP, FERS, FRSC


Professor, Division of Respirology, Department of Medicine, and Dean and Vice-President, Faculty of Health Sciences, McMaster University, St. Joseph’s Healthcare

Dr. O’Byrne is world renowned for his research on asthma that is the result of allergies.

Sector: Clinical/Academic

Diana Royce | AllerGen NCE


Diana Royce, EdD


President and CEO, AllerGen NCE Inc.

Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.

Padmaja Subbarao | clinical/academic, Toronto, ON


Padmaja Subbarao, MD, FRCPC, Msc. (Epid)


Director, Pulmonary Function Laboratory, and Clinician-Scientist, Respirologist, Hospital for Sick Children; Associate Professor, Department of Paediatrics, University of Toronto; Director, CHILD Cohort Study

Dr. Subbarao’s primary research interest is in the early determinants and development of asthma. Specifically, she is studying changes in infant lung function biomarkers of inflammation in this understudied group to elucidate the effect of environment and viruses on the early development of disease.

Sector: Clinical/Academic